
|Articles|July 1, 2001
Supplements and Featured Publications
- New Developments in the Treatment of Irritable Bowel Syndrome
- Volume 7
- Issue 8 Suppl
Continuing Medical Education Quiz
Advertisement
Articles in this issue
over 24 years ago
Participating Facultyover 24 years ago
Introductionover 24 years ago
Defining and Diagnosing Irritable Bowel Syndromeover 24 years ago
Drug Therapy Options for Patients with Irritable Bowel Syndromeover 24 years ago
Selected AbstractsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5















































